Lexiscan (regadenoson) - GE Healthcare, Astellas, Gilead
Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics (clinicaltrials.gov) - Sep 5, 2026 - P=N/A | N=68 | Active, not recruiting | Sponsor: University of Cincinnati | Trial completion date: Jul 2026 ➔ Jul 2027 | Trial primary completion date: Jul 2026 ➔ Jul 2027 
Trial completion date • Trial primary completion date • Cardiovascular • Coronary Artery Disease
http://clinicaltrials.gov/ct2/show/NCT01719016
 
Sep 5, 2026
 
Prev Next